RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...

In a report released today, Nik Modi from RBC Capital maintained a Hold rating on Clorox (CLX – Research Report), with a price target of ...

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...

Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis ...

UBS Group AG is a holding company ... facilitating clients raising debt and equity from the public, private, and capital markets, cash and derivatives trading. The Non-Core and Legacy segment ...

UBS Global Research in a note dated Monday downgraded Uniqa Insurance Group (ETR: UNIQ) to a "sell" rating, citing a less ...

UBS Global Research has upgraded Zalando SE (ETR: ZALG) to a "buy" from a "neutral" rating, citing signs of a potential turnaround driven by structural growth and ...